peptide vs semaglutide Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Know the Differences Between Semaglutide

Semaglutide's positive effects for PAD appeared to be only weakly linked to weight loss

have shown that a peripheral injection of GLP-1, irrespective of its site of infusion (vena cava, intraperitoneal cavity, or portal vein), reduced food intake without affecting the subsequent inter-meal interval, the size of subsequent meals, or the cumulative food intake [88]

The pivotal trials for both diabetes and weight management (SUSTAIN and STEP programs) excluded pregnant women and required contraception during participation, limiting our understanding of fertility effects

5 In addition, up to 46% of participants achieved an A1C below 5.7%, the threshold for normoglycemia